Jazz Pharmaceuticals (JAZZ) Change in Inventory (2016 - 2025)
Jazz Pharmaceuticals has reported Change in Inventory over the past 16 years, most recently at -$7.7 million for Q4 2025.
- Quarterly results put Change in Inventory at -$7.7 million for Q4 2025, down 141.36% from a year ago — trailing twelve months through Dec 2025 was $86.0 million (up 88.93% YoY), and the annual figure for FY2025 was $86.0 million, up 88.93%.
- Change in Inventory for Q4 2025 was -$7.7 million at Jazz Pharmaceuticals, down from $31.9 million in the prior quarter.
- Over the last five years, Change in Inventory for JAZZ hit a ceiling of $35.6 million in Q1 2025 and a floor of -$7.7 million in Q4 2025.
- Median Change in Inventory over the past 5 years was $8.9 million (2022), compared with a mean of $12.2 million.
- Biggest five-year swings in Change in Inventory: surged 1229.42% in 2024 and later plummeted 141.36% in 2025.
- Jazz Pharmaceuticals' Change in Inventory stood at $15.0 million in 2021, then tumbled by 105.45% to -$816000.0 in 2022, then skyrocketed by 272.06% to $1.4 million in 2023, then surged by 1229.42% to $18.7 million in 2024, then plummeted by 141.36% to -$7.7 million in 2025.
- The last three reported values for Change in Inventory were -$7.7 million (Q4 2025), $31.9 million (Q3 2025), and $26.2 million (Q2 2025) per Business Quant data.